4//SEC Filing
Zietsman Brian 4
Accession 0001437749-12-009903
CIK 0000352747other
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 4:24 PM ET
Size
8.9 KB
Accession
0001437749-12-009903
Insider Transaction Report
Form 4
Zietsman Brian
Executive Director, Finance
Transactions
- Award
Stock Option
2012-09-27+39,600→ 159,600 totalExercise: $0.25Exp: 2022-09-26→ Common Stock (39,600 underlying) - Award
Stock Option
2012-09-27+250,000→ 1,034,600 totalExercise: $0.10From: 2013-09-27Exp: 2022-09-26→ Common Stock (250,000 underlying) - Award
Stock Option
2012-09-27+625,000→ 784,600 totalExercise: $0.10From: 2013-09-27Exp: 2022-09-26→ Common Stock (625,000 underlying)
Footnotes (1)
- [F1]19,800 stock options will become exercisable on August 1, 2013 and 19,800 stock options will become exercisable on August 1, 2014
Documents
Issuer
UNIGENE LABORATORIES INC
CIK 0000352747
Entity typeother
Related Parties
1- filerCIK 0001547012
Filing Metadata
- Form type
- 4
- Filed
- Sep 30, 8:00 PM ET
- Accepted
- Oct 1, 4:24 PM ET
- Size
- 8.9 KB